Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData EP News Bureau Sep 21, 2023 The National Institute for Health and Care Excellence (NICE) provided guidance in August 2023 explaining that where triple therapy…
